# Erlotinib

NDC: 63304-135
Generic name: Erlotinib
Labeler / Manufacturer: Sun Pharmaceutical Industries, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20191105

FDA application: ANDA210300

## Active ingredients

- ERLOTINIB: 150 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"63304-135"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=63304-135
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e36fa076-e23b-437f-bbd2-0433ce333175